Zobrazeno 1 - 3
of 3
pro vyhledávání: '"F. Berenice Baez-Revueltas"'
Autor:
Matthew Wasserman, Maria Gabriela Palacios, Ana Gabriela Grajales, F. Berenice Baez/Revueltas, Michele Wilson, Cheryl McDade, Raymond Farkouh
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 3, Pp 560-569 (2019)
Introduction: Pneumococcal diseases caused by Streptococcus pneumoniae represent a significant health and economic burden. Mexico has benefited from the inclusion of the 7-valent (PCV7) and 13-valent pneumococcal conjugate vaccines (PCV13) since thei
Externí odkaz:
https://doaj.org/article/bce77725061b4dd3b159e912c6f0891b
Autor:
Erika Sifuentes, Enrique Soto-Perez-de-Celis, Yanin Chavarri Guerra, Cynthia Villarreal-Garza, Jose Antonio Acevedo, F. Berenice Baez-Revueltas, Fernando Lara-Medina, Santiago Ruano
Publikováno v:
Journal of Clinical Oncology. 31:e11533-e11533
e11533 Background: The most accurate definition of pathologic complete response (pCR) in HER2+ BC patients (pts) receiving T-based neoadjuvant chemotherapy associated with improved DFS is controversial, particularly regarding the role of residual duc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29cebff8adddf80646ba69dc3f890eb6
https://doi.org/10.1200/jco.2013.31.15_suppl.e11533
https://doi.org/10.1200/jco.2013.31.15_suppl.e11533
Autor:
Enrique Soto-Perez-de-Celis, Santiago Ruano, Yanin Chavarri Guerra, Cynthia Villarreal-Garza, F. Berenice Baez-Revueltas, Fernando Lara-Medina, Erika Sifuentes
Publikováno v:
Journal of Clinical Oncology. 31:634-634
634 Background: Neoadjuvant treatment identifies subgroups of patients (pts) with different prognosis. In HER2+ BC, some tumors have been reported to be more sensitive to anti-HER2 therapy than others. We conducted an exploratory analysis in HER2+ BC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7ff12955f8c087a93bf9fe830e28ac2
https://doi.org/10.1200/jco.2013.31.15_suppl.634
https://doi.org/10.1200/jco.2013.31.15_suppl.634